AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Supernus Pharmaceuticals, Inc.
$41.92
-$7.55 (-15.26%)
Previous Close
$41.84
Day Range
$39.53$43.72
Year Range
$37.54$59.68
Market Cap
2.44B
AVG Volume
898.75K
Trailing/Forward PE
-55.06/10.15
PEG ratio
5.13
Dividend Yield
-
Next Earnings Date
2027-02-23
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: SUPN
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 23 Feb 2027.
Video analysis: SUPN
All videosNo video analysis for this stock yet. Request one from our team.
News: SUPN
Similar companies
-
Neurocrine Biosciences, Inc.
NBIX
·
NASDAQ
Compare
-
Praxis Precision Medicines, Inc.
PRAX
·
NASDAQ
Compare
-
Xenon Pharmaceuticals Inc.
XENE
·
NASDAQ
Compare
-
Vanda Pharmaceuticals Inc.
VNDA
·
NASDAQ
Compare
-
Axsome Therapeutics, Inc.
AXSM
·
NASDAQ
Compare
-
Acadia Pharmaceuticals Inc.
ACAD
·
NASDAQ
Compare